Genes2Me provides a whole range of focused NGS panels dedicated and capable of providing diagnosis and prognostic solutions for prevention as well as treatment of a variety of genetic and somatic cancers, Cardiovascular, Respiratory and Neurological disorders and capture of drug metabolism related genes.
Our NGS panels and kits deliver end-to-end flexibility for every sequencing need from differential expression analysis to variant and mutation detection. Whether targeting specific regions or exploring the entire exome, transcriptome, or genome, these solutions overcome workflow challenges and accelerate the path to actionable insights.
Our advanced nucleic acid probes, designed with base-pair complementarity, selectively capture target regions in a liquid-phase environment for superior DNA/RNA enrichment. Paired with high-throughput sequencing, this approach ensures accurate detection of critical genetic and somatic mutations delivering deep insights for research and clinical breakthroughs.
Create high-quality NGS libraries optimized for seamless compatibility across leading sequencing platforms including Illumina®, Ion Torrent™, MGI’s DNBSEQ, and Element Biosciences for unmatched performance and reliability.
Expertly curated and optimized NGS panels deliver exceptional genomic coverage, ensuring accurate, high-confidence results for every application.
Download useful documents and technical information for NGS Solutions.
Since its inception in 2016, Genes2me has been constantly striving towards setting a benchmark in the diagnostics space by introducing premium quality (Made in India) diagnostic kits which are CE-IVD, ISO-13485:2016, and ISO 9001:2015 certified, assuring our clients of unparalleled quality and compliance with international standards.
All products listed in the catalogue are the products of Genes2Me Private Limited. Apart from that, all other product names, trademarks and logos wherever used in the catalogue are the property of their respective owners.
© 2025 Genes2me. All rights reserved.